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ABSTRACT

Spiramycin (SPI) and oxytetracycline (OTC) are widely used antibacterial drugs. Thus, a great attention has been
focusing on the development of a simple and selective analytical procedure for fast analysis of these compounds in
a binary pharmaceutical mixture. Herein, we report four simple and reproducible spectrophotometric methods for
determination of SPI and OTC in a binary mixture and in veterinary pharmaceutical formulations. A ratio difference (RD)
based on the difference in the amplitude of the ratio spectra and dual wavelength methods were proposed for sensitive
and selective determination of SPI in presence of OTC. Furthermore, Constant Value and Concentration Value based
spectrophotometric methods were suggested for simultaneous determination of SPI and OTC in a binary mixture. The
methods were successfully applied for the determination of SPI and OTC over the concentration range from 4.0 to 36.0
µg mL-1 and from 2.0 to 32.0 µg mL-1, respectively. The proposed methods were validated according to the International
Conference on Harmonization (ICH) guidelines. The methods are accurate (100±1%), precise (%RSD ≤1.5) and costeffective for determination of SPI and OTC in binary mixtures.
Key Words: Concentration value, Constant value, Dual wavelength, Oxytetracycline, Ratio difference, Spectrophotometry,
Spiramycin.
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INTRODUCTION
Spiramycin (Figure 1) is a macrolide antibacterial
drug which is used to treat susceptible bacterial infections.
It has also been used in the protozoal infections
cryptosporidiosis and toxoplasmosis[1]. Spiramycin is
a mixture of basic antimicrobial substances produced
by the growth of Streptomyces ambofaciens and
consistes of spiramycin I (C43H74N2O14, MW= 843.1)
(about 63%), spiramycin II (C45H76N2O15, MW=885.1)
(about 24%) and spiramycin III (C46H78N2O15 MW = 899.1)
(about 13%)[2]. Oxytetracycline, on the other hand, is
a tetracycline derivative which has a pharmacological
action similar to that of tetracycline (Figure 1)[1]. Although
spiramycin is produced by some pharmacopeias as a
reference standard[3], there is no pharmacopeial method
that can be followed for determination of spiramycin in
veterinary dosage forms.

chromatography[11-17], thin layer chromatography[18,19],
spectrophotometry[20,21] and electrochemical methods[22] for
the assay of OTC. A densitometic method was reported for
simultaneous determination of SPI and OTC in a binary
mixture[23]. The proposed method uses a mobile phase
which consists of environmentally unfavourable solvents.
Additionally, the desitometric chromatogram that shows
semiltaneous separation and determination of SPI and
OTC was not displayed.
In this his work, we report new simple and reliable
spectrophotometric methods for the determination of SPI
and OTC in a mixture without the need of separation or
sophisticated manipulation steps. The Constant Value and
Concentration Value methods use a normalized divisor
which could be calculated mathematically to get a plateau
region through which the compound can be determined
and not affected by any change in the wavelength.
Concentration value is considered as a new approach in
spectrophotometry because it is the first spectrophotometric
method that determines the concentration of the drugs

Several non-official analytical methods, however, were
reported for the assay of SPI and OTC. These methods
include liquid chromatography[4-8] and spectrophotometric
methods[9,10] for the assay of SPI; and liquid
Personal non-commercial use only BFPC copyright © 2020. All rights reserved
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without using regression equations, where the analysis
solely depends on the spectral representation rather than
the calibration curves[24]. Also, in the ratio difference
method, the difference in the amplitude between two
points on the ratio spectra of a mixture was found to be
directly proportional to the concentration of the component
of interest; independent of the interfering component.

Additionally, a dual wave length method was used for the
determination of one component in presence of the other.
The proposed methods were successfully applied for the
simultaneous determination of SPI and OTC in laboratory
prepared mixtures and in pharmaceutical dosage form.

Spiramycin I
R=H
Spiramycin II R=COCH3
Spiramycin III R=COCH2CH3
(SPI)

(OTC)

Fig 1: Chemical structure of Spiramycin (SPI) and Oxytetracycline (OTC).

2

Experimental

2.3

2.1

Apparatus

All preparations were carried out using double distilled
water, previously filtered through a 0.45 µm filter paper.

All spectrophotometric measurements were carried
out using Shimadzu UV-1601 PC spectrophotometer
(Kyoto, Japan) provided with two matched 1-cm quartz
cells and spectroscopy software version (2.21). The
spectral band width is 0.1 nm and the scanning speed is
2800 nm/min.

2.2

Materials



Pure standards



Stock standard solutions

An accurately weighed 10.0 mg of SPI and OTC were
dissolved each in 100 mL water to give stock standard
solutions with a concentration of 100.0 µg mL-1 for each
compound.


Linearity solutions

Linearity solutions covering the concentration range
from 4.0-36.0 and 2.0-32.0 µg mL-1 for SPI and OTC,
respectively, were prepared by appropriate dilution from
the corresponding stock standard solutions. The spectrum
of each individual solution was recorded in the range from
200 to 400 nm and stored in the computer.

Spiramycin (purity=98.80%) was obtained from Henan
Topfond Pharmaceuicals Co., Ltd (Zhumadian, China).
Oxytetracycline HCl (purity=97.60%) was obtained from
Pharma Swede, 10th of Ramadan, Egypt.



Working solutions

Pharmaceutical formulation

Arcospirox® powder (batch number: 100716/A)
contains 107.9 mg (OTC) and 71.8 mg (SPI) per 1.0 gram
was obtained from Arco Pharma, Cairo, Egypt.
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For the Ratio Subtraction Constant Value (RS-CV)
and Ratio Subtraction Concentration Value (RS-Conc.
value) of Spiramycin, the recorded zero order spectra
of the laboratory prepared mixtures were divided by the
absorption spectrum of standard OTC (32.0 µg mL-1).
Then, the amplitudes in the plateau region at λ 274-284
nm (the constant) were recorded and subtracted from the
obtained ratio spectra, respectively. Then, multiplying the
obtained spectra by OTC (32.0 µg mL-1) to get the zero
spectra of SPI and application of Constant Value (CV) and
Concentration Value (Conc. value) methods.

METHODS
2.4.1. Linearity and Construction of Calibration
Curves
2.4.1.1 Ratio difference method (RD)
The recorded spectra of SPI are divided by the recorded
spectrum of 32.0 µg mL-1 OTC and the difference in the
amplitude of the ratio spectra (SPI/OTC) at 232 and
292 nm (∆P232–292) is plotted against the corresponding
concentrations of SPI.

For the other methods, applying the proposed methods,
the concentrations of SPI and OTC in the prepared mixtures
are calculated from the corresponding equations.

2.4.1.2 Dual wavelength method (DWL)

2.4.3 Application of the proposed methods for the
determination of SPI and OTC in pharmaceutical
formulation

The SPI spectra are recorded and the difference between
the absorbance at 232 and 375.5 nm was plotted against the
corresponding concentration. Note: the difference between
the absorbance at 232 and 375.5 nm is zero for OTC.

An Accurately weighed 92.7 mg of the Arcospirox
powder equivalent to 10.0 mg of OTC and 6.65 mg SPI
was transferred into 100- mL volumetric flask, dissolved
in 50 mL water and sonicated for 15 min. Then, the flask
was completed to the mark with water. Further dilution
was carried out by transferring 1, 2 and 3 mL into a series
of 10-mL volumetric flasks.

2.4.1.3 Constant Value (CV) and Concentration
Value (Conc. Value) of Oxytetracycline:
In these methods the zero-order spectrum of the more
extended component (OTC) was divided by the zero order
normalized spectrum divisor of OTC (1 µg mL-1); the
constant was obtained from the plateau region which is
related to the concentration of OTC. In the CV method the
regression equation was computed relating the constant to
OTC concentration, while for the Conc. Value there was no
need for regression equation. The concentration is equal to
the constant in the plateau region can be directly obtained
from the graphical representation.

The solutions were subjected to the analytical methods
which are described previously. The concentrations of
SPI and OTC were calculated from the corresponding
regression equations. For the (RS-CV) and (RS-Conc.V)
methods, the procedure mentioned under analysis of
laboratory prepared mixtures was used. The validity of
the methods was assessed using the standard addition
technique.

2.4.1.4 Ratio Subtraction Constant Value (RS-CV)
and Ratio Subtraction Concentration Value (RSConc. Value) of Spiramycin:

RESULTS AND DISCUSSION
SPI and OTC are widely used antibacterial veterinary.
Most of antibacterial veterinary dosage forms are
produced with combination of SPI and OTC. Direct
spectrophotometric determination of SPI and OTC in a
binary mixture is difficult due to the sever overlap of the
spectra of the two compounds (Figure 2). Therefore, this
work was developed to enable simultaneous determination
of SPI and OTC in veterinary dosage forms.

The spectra of pure SPI were divided by its normalized
spectrum divisor of SPI; the constant was obtained from
the plateau region which is related to the SPI concentration.
The calibration curve was constructed between the
concentration and the corresponding constant for the (CV)
method. While for (Conc. Value) the concentration can be
directly obtained from the graphical representation.

2.4.2 Application of the proposed methods for
the determination of SPI and OTC in laboratory
prepared mixtures

a
b
s

Into a series of 10-mL volumetric flasks, aliquots of
SPI and OTC were accurately transferred from the stock
standard solutions with the ratios of 1:8, 1:4, 1:1, 8:1 and
4.5:8 for SPI and OTC, respectively. Afterwards, each
flask was completed to the mark with water. The spectra
of the prepared mixtures were recorded and stored in the
computer.

Wave length (nm)
Fig 2: Zero order spectra of 20 µg mL-1 SPI (-) and 8 µg mL-1
OTC (---) recorded against water as blank.
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3.1

Method development and optimization



Ratio difference method (RD)

232 and 375.5 nm, whereas, SPI has significant difference
in the absorbance at these two wavelengths. Calibration
graph was constructed and the concentration of SPI can
be calculated from the following regression equation (2):

The major factors affecting the ratio difference[25] are
the divisor concentration and the selected wavelength. The
selected value for the divisor is a compromise between
minimal noise and maximum sensitivity. Therefore,
different concentrations including 4.0, 16.0 and 32.0
µg mL-1 of OTC as a divisor were tested. Satisfactory
recovery, repeatability and signal to noise ratio were
obtained with 32.0 µg mL-1 of OTC as a divisor. The second
factor is the wavelengths at which the measurements
are performed. Any two wavelengths can be selected
provided that they exhibit difference in the amplitude of
the ratio spectrum, and a good linearity is present at each
wavelength individually.

ΔA = 0.0242 C – 0.001,

232 nm

Wave length (nm)
Fig. 4: Zero order absorption spectra of 20 µg mL-1(---) SPI, and 8
µg mL-1 OTC (—). The arrows showing the selected wavelengths
for dual wavelength calculations.


Constant Value and Concentration Value
for Oxytetracycline

(1)

Where ∆P is the difference in the amplitude at 232 and
292 nm, C is the concentration of SPI in µg mL-1 and r is
the correlation coefficient.

OTC spectrum is extended more than SPI as shown in
(Figure 2). So that when the spectra of mixtures of OTC
and SPI are divided by the spectrum of normalized divisor
of OTC, a constant at the plateau region in the extended
part of the spectrum (250 - 400 nm) was obtained as shown
in (Figure 5).

232 nm
a
b
s

375.5 nm

a
b
s

A linear relationship is obtained by plotting the
differences in the amplitude at 232 and 292 nm against the
corresponding concentration of SPI, The linear regression
equation (1) is found to be
r = 0.9997

(2)

Where ∆A is the absorbance difference at 232 and
375.5 nm, C is the concentration of SPI in µg mL-1 and r is
the correlation coefficient.

The values of amplitude at 232 and 292 nm were
chosen for determination of SPI in presence of OTC. The
best results were obtained with OTC concentration of 32.0
µg mL-1 as a divisor (Figure 3).

ΔP = 0.0337 C – 0.0005,

r = 0.9998

292 nm

This constant is equivalent to the concentration of OTC
as it is resulting from dividing the spectra of the mixture by
the normalized spectra of OTC of 1 µg mL-1.
(SPI +OTC ) / OTC̀ ʹ = SPI/ OTC̀ ʹ + OTC/ OTC̀ ʹ
(SPI +OTC ) / OTC̀ ʹ = SPI/ OTC̀ ʹ + constant

Wave length (nm)

Where OTC̀ ʹ is a normalized divisor with concentration
of 1 µg mL-1.

Fig. 3: Ratio spectra of 20.0 µg mL SPI (-), and a binary mixture
of 20.0 µg mL-1 SPI and 20 µg ml-1OTC (---) using 32.0 µg mL-1
OTC as a divisor. The arrows showing the selected wavelengths.
-1



For constant value method, a calibration curve between
the constant and the corresponding concentration is
constructed, where the concentration of OTC is obtained
from regression equation (3):

Dual wavelength method (DWL)

The dual wavelength method depends on the difference
in the absorbance at two wavelengths on the spectra which
is directly proportional to the component of interest and
independent of the interfering component.

Const. = 1.0001 C – 0.062,

r = 0.9999

(3)

Where Const. is the constant at the plateau region
(250-400 nm), C is the concentration of OTC in µg mL-1
and r is the correlation coefficient.

The requirement for dual wavelength method is
the selection of two wavelengths where the interfering
component shows the same absorbance while the component
of interest shows significant difference in absorbance.
(Figure 4) shows that OTC has the same absorbance at

While for Concentration Value method, the
concentration was directly obtained from the spectra
plateau region using that constant. The results of both
methods were compared and both have good recoveries.
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While for Concentration Value, the concentration is
directly obtained from the spectra plateau region using that
constant. The results of the two methods were compared
and showed good recoveries.

a
b
s

a
b
s

Wave length (nm)
Fig. 5: The constant value obtained after the division of the zero
order spectra of OTC (2.0–32.0 µg mL-1) by the spectrum of
normalized 1.0 µg mL-1 OTC as divisor.


Ratio Subtraction (RS) Constant Value
and Ratio Subtraction Concentration Value for
Spiramycin:

Wave length (nm)
Fig. 6: The constant value obtained after the division of the
zero order spectra of SPI (4.0–36.0 µg mL-1) by the spectrum of
normalized 1.0 µg mL-1 SPI as divisor.

SPI was resolved from OTC by RS according to the
following equations:

3.2

(SPI +OTC) / OTC̀ ʹ = SPI/ OTC̀ ʹ + OTC/ OTC̀ ʹ

Methods validation has been performed according to
ICH guidelines[26].

SPI/ OTC̀ ʹ + constant – constant = SPI/ OTC̀ ʹ
SPI/ OTC̀ ʹ x OTC̀ ʹ = SPI



Then, the obtained spectra were divided by a normalized
spectrum divisor of SPI. So, the constant obtained in the
plateau region is related to SPI concentration as shown in
(Figure 6).

r = 0.9997

Linearity

The linearity of the proposed methods is evaluated
by analyzing eight different concentrations of standard
solutions ranging from 4.0-36.0 µg mL-1 for SPI and from
2.0-32.0 µg mL-1 for OTC in triplicates. The values of
correlation coefficients are close to unity indicating good
linearity, the regression equations are summarized in
(Table 1).

For Constant Value, a calibration curve between
that constant and the corresponding concentration was
constructed and the concentration of SPI was obtained
from the regression equation (4)
Const. = 1.0263 C – 0.1277,

Method validation



(4)

Range

The calibration range was established by considering
of the practical range necessary to Beer’s law and the
concentration of SPI and OTC present in the pharmaceutical
preparations to give satisfactory accuracy, precision and
linearity (Table 1).

Where Const. is the constant at the plateau region
(225-245 nm), C is the concentration of SPI in µg.mL-1 and
r is the correlation coefficient.

Table 1: Validation resultsof the proposed spectrophotometric methods for the determination of Spiramycin (SPI) and Oxytetracycline HCl
(OTC).
Parameters

(RD)

Concentration range
(μg mL-1) linearity

(DWL)

(CV)

(Conc.value)

SPI

SPI

OTC

SPI

OTC

4.0 – 36.0

4.0 – 36.0

2.0 – 32.0

4.0 – 36.0

2.0 – 32.0

Slope

0.037

0.024

1.026

1.000

---

---

Intercept

0.0005

0.001

0.128

0.062

---

---

Correlation coefficient (r)

0.9997

0.9998

0.9997

0.9999

---

---

Accuracy (mean ± S.D.)

100.33± 0.87

99.95± 1.16

100.64 ± 1.12

100.39 ± 1.09

101.19 ± 0.63

99.68± 0.99

Repeatabilitya

1.51

1.54

0.61

0.35

0.61

0.68

0.57

1.12

0.87

1.66

1.11

1.33

Intermediate precision

b

a The intraday (n = 3), average of three different concentrations repeated three times within day.
b The interday (n = 3), average of three different concentrations repeated three times in three successive days.
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Selectivity

The selectivity of the proposed methods is assessed by
the analysis of six different laboratory prepared mixtures

containing different ratios of SPI and OTC; satisfactory
results were obtained and presented in (Table 2).

Table 2: Determination of Spiramycin (SPI) and Oxytetracycline HCl (OTC) in laboratory prepared mixtures by the proposed methods.
No. of
mixtures

(RD)

(DWL

(CV)

(Conc.value)

% Recovery*

% Recovery*

% Recovery*

% Recovery*

Claimed conc. taken in µg mL-1

SPI

OTC

SPI

SPI

SPI

OTC

SPI

OTC

1

4.0

32.0

98.31

101.24

100.24

100.36

101.87

100.18

2

8.0

32.0

100.17

101.23

100.10

99.99

101.13

99.81

3

16.0

16.0

101.47

99.10

101.52

98.88

100.05

98.5

4

20.0

20.0

101.96

98.69

100.49

99.42

100.25

99.13

5

32.0

4.0

99.79

98.85

99.15

100.11

101.36

98.58

6

36.0

8.0

100.04

99.68

100.85

99.14

100.14

98.37

100.29 ± 1.29

99.79 ± 1.16

Mean ± SD

100.39± 0.79 99.65 ± 0.59 100.80± 0.76 99.09 ± 0.75

* Average of three determinations.



Accuracy



The accuracy of the results was studied by applying
the proposed methods for determination of five different
samples of SPI and OTC. The accuracy is presented in
(Table 1).

Precision

The precision was studied by applying the proposed
methods for determination of three different concentrations
of each of SPI and OTC, which were analyzed three
times intra-daily for repeatability and inter-daily on three
different days for intermediate precision. The precision
results are summarized in (Table 1).

To ascertain the accuracy of the proposed methods,
recovery studies are carried out by standard addition
technique at three different levels (Table 3).

Table 3: Determination of Spiramycin (SPI) and Oxytetracycline HCl (OTC) in their pharmaceutical formulation by the proposed methods
and application of standard addition technique
Standard addition technique
Pharmaceutical
formulation

Arco
spirox®
WSP batch
number:
100716/A

%Found* ± S.D.
RD

DWL

SPI

SPI

99.80
±1.05

CV
SPI

Added
µg.mL-1

Added
µg.mL-1
RD

DWL

SPI

OTC

SPI

SPI

SPI

OTC

SPI

OTC

4.0

4.0

100.75

101.88

99.38

99.51

98.80

101.83

8.0

8.0

101.38

101.04

99.48

101.48 100.50 101.45

16.0

16.0

101.00

99.78

99.70

101.26 101.53

101.04
± 0.32

100.90
± 1.06

99.52
±0.16

100.75 100.28 100.96
± 1.08 ±1.38 ± 1.19

Conc. value
OTC

SPI

OTC

101.11 100.11 101.30 100.27 100.96
± 0.44 ±1.69 ±0.79 ±0.87 ±1.02

Mean ± S.D

Average of three determinations.*
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Statistical analysis
methods[10, 13]. The calculated t- and F-values are found to
be less than the theoretical ones, confirming accuracy and
precision at 95% confidence level (Table 4).

Results obtained by the proposed methods for
determination of pure SPI and OTC are statistically
compared with those obtained by applying the reported

Table 4: Statistical comparison of the results obtained by applying the proposed methods and published methods
Parameters

Mean%
S.D.
n
Variance
Student's t-test
(2.132)a
F-test (6.39)a

RD

DWL

CV

Conc. value

Reported methods[10, 13]

(SPI)

(SPI)

(SPI)

(OTC)

(SPI)

(OTC)

(SPI)b

(OTC)c

100.33

99.95

100.64

100.39

101.19

99.68

100.09

99.48

0.87

1.16

1.12

1.09

0.63

0.99

1.03

0.88

0.76

1.35

1.25

1.18

0.39

0.98

1.06

0.77

0.69

0.84

0.21

0.29

0.16

0.75

-

-

1.39

1.27

1.17

1.53

2.72

1.27

-

-

a The values in parenthesis are the corresponding theoretical values of t and F at (P = 0.05).
b charge transfer complex between SPI and quinalizarin producing charge transfer complex in methanolic medium ∆λ = 568 nm.
c HPLC method using mobile phase; methanol-0.01 M oxalic acid, pH 3.0 (30:70, v/v) at 250 nm using a Silasorb C8 column.

CONCLUSION

and tylosin in feedingstuffs with HPLC–UV/DAD at
1ppm level, Journal of Pharmaceutical and Biomedical
Analysis 36 (2004) 317-325. https://doi.org/10.1016/j.
jpba.2004.06.010.

This work provides four different spectrophotometric
methods for the simultaneous analysis of SPI and OTC
in veterinary dosage forms. The developed Concentration
Value method could determine both drugs without the use
of regression equations; this was attained directly from
the graphical representation. The proposed methods do
not need any sophisticated apparatus or any preliminary
separation steps and can be easily applied in quality
control laboratories for the determination of SPI and OTC
in presence of each other in veterinary pharmaceutical
formulation.
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